EXCLUSIVE EVENT
I N V I T A T I O N
Human Papilloma Virus (HPV)
A Test to Assess Risk of Developing Cervical Cancer
The HPV test is a highly sensitive*, non-invasive, DNA based
testing method that evaluates the presence of 13 types of
high-risk HPV viruses in the sample of cervical cells. Studies
show that the HPV test complements the Pap test as the two
tests used together are highly effective for early detection of
cervical cancer
Who should get tested? Anyone who has ever been sexually
active (that is, engaged in skin-to-skin sexual conduct,
including vaginal, anal, or oral sex) can get HPV.
Insights gained from running an HPV test can help clinicians
to detect the presence of high-risk virus before any changes
can be detected in the cells of the cervix.
About HPV
Cervical Cancer
Diagnosis and Tests
Overview of HPV Test at LifeLabs
Reporting
Cervical Cancer Screening Guidelines
Screening Recommendations
Treatment Options & Management
WITH GUEST SPEAKER
Dr. Mona Kamel M.B., B. Ch
Discipline Head
Cytopathology, LifeLabs
Surgical Pathologist, LifeLabs
Lecturer, University of Toronto, Toronto, ON
ONE DAY VIRTUAL ONLY EVENT
email Glover@rmalab.com to register
THURS, JANUARY 20th
9:00AM PST – 10:00AM PST
